D-0363-2026 Class II Ongoing
FDA drug recall D-0363-2026 was initiated by ACME UNITED CORPORATION on Jan 20, 2026 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing.
Recall details
- Product Type
- Drugs
- Report Date
- Mar 11, 2026
- Initiation Date
- Jan 20, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
Product description
Max Packaging Antibacterial Towelette (Benzalkonium Chloride 0.13%), 1 towelette, 4x7, Max Packaging, Made in the USA, NDC 59647-750-01
Reason for recall
CGMP Deviations
Distribution pattern
Nationwide within the United States
Code information
Lot #: MN24523, Exp. Date July 2028; MN27123, Exp. Date Aug 2028; MN28223, Exp. Date Sep 2028.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0363-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026